ClinicalTrials.Veeva

Menu

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

Status Epilepticus
Perfusion Weighted MRI
Ictal-interictal Continuum
Perfusion CT
Positron-emission Tomography

Treatments

Diagnostic Test: MRI scan including arterial spin labelling of the brain
Diagnostic Test: FDG-PET scan of the brain
Diagnostic Test: CT perfusion scan of the brain

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators propose a prospective study of 20 control subjects and 180 consecutive patients with possible non-convulsive status epilepticus (NCSE). The investigators will obtain three functional images of the brain:

  1. Fluorodeoxyglucose positron emission tomography (FDG-PET)
  2. Perfusion (and structural) magnetic resonance (MR) images
  3. Computed tomography (CT) perfusion.

Brain hypermetabolism/hyperperfusion is a strong argument to confirm a diagnosis of non-convulsive status epilepticus.

The aim is to determine which of the three functional imaging techniques is the most sensitive and easy to obtain in the detection of hypermetabolism/hyperperfusion. The investigators will determine which EEG patterns are associated with hypermetabolism/perfusion.

The investigators will further study and describe the management with antiseizure medication and outcome of the group with possible non-convulsive status epilepticus WITH hypermetabolism/hyperperfusion versus the group with possible non-convulsive status epilpticus WITHOUT hypermetabolism/hyperperfusion.

The investigators will make recommendations for an imaging protocol in possible NCSE for widespread use. The aim is to offer guidelines to incorporate imaging in the diagnosis, management and prognosis of NCSE in patients with the ictal-interictal continuum.

Enrollment

200 estimated patients

Sex

All

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The patient has possible non-convulsive status epilepticus with scalp or invasive EEG with ictal-interictal continuum patterns on EEG

Exclusion criteria

  • The patient has a contra-indication for MRI such as metal implants
  • The patient has contrast sensitivity
  • The patiensuffers from claustrophobia or cannot tolerate confinement during PET-MRI scanning procedures

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Possible non-convulsive status epilepticus with ictal-interictal continuum EEG patterns
Other group
Description:
Patients with a possible non-convulsive status epilepticus, according to American Clinical Neurophysiology Criteria (ACNS) (2021).
Treatment:
Diagnostic Test: CT perfusion scan of the brain
Diagnostic Test: FDG-PET scan of the brain
Diagnostic Test: MRI scan including arterial spin labelling of the brain
Healthy control subjects
Other group
Description:
Healthy control subjects.
Treatment:
Diagnostic Test: CT perfusion scan of the brain
Diagnostic Test: FDG-PET scan of the brain
Diagnostic Test: MRI scan including arterial spin labelling of the brain

Trial contacts and locations

1

Loading...

Central trial contact

Jeroen Gijs, MD; Wim Van Paesschen, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems